An all-purpose antimalarial drug target

W. Armand Guiguemde; R. Kiplin Guy

doi:10.1016/j.chom.2012.05.008

An all-purpose antimalarial drug target

W. Armand Guiguemde
, R. Kiplin Guy

Research output: Contribution to journal › Short survey › peer-review

7 Scopus citations

Abstract

The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

Original language	English (US)
Pages (from-to)	555-557
Number of pages	3
Journal	Cell Host and Microbe
Volume	11
Issue number	6
DOIs	https://doi.org/10.1016/j.chom.2012.05.008
State	Published - Jun 14 2012
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1016/j.chom.2012.05.008

Find It

Find It at U of M Libraries

Cite this

@article{d9d491491ef948069ebc55da335b8d0b,

title = "An all-purpose antimalarial drug target",

abstract = "The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.",

author = "Guiguemde, \{W. Armand\} and Guy, \{R. Kiplin\}",

year = "2012",

month = jun,

day = "14",

doi = "10.1016/j.chom.2012.05.008",

language = "English (US)",

volume = "11",

pages = "555--557",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - An all-purpose antimalarial drug target

AU - Guiguemde, W. Armand

AU - Guy, R. Kiplin

PY - 2012/6/14

Y1 - 2012/6/14

N2 - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

AB - The recent re-emphasis on malaria eradication has made developing drugs that block transmission and terminate latent disease critical. Most drugs do not affect the liver stages - an ability that is crucial to the latter goal. Addressing this problem, Hoepfner et al. (2012) uncover the parasite's lysyl-tRNA synthetase as a druggable target.

UR - https://www.scopus.com/pages/publications/84862286411

UR - https://www.scopus.com/pages/publications/84862286411#tab=citedBy

U2 - 10.1016/j.chom.2012.05.008

DO - 10.1016/j.chom.2012.05.008

M3 - Short survey

C2 - 22704614

AN - SCOPUS:84862286411

SN - 1931-3128

VL - 11

SP - 555

EP - 557

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 6

ER -

An all-purpose antimalarial drug target

Abstract

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this